Komori
Nissan Chemical (4021) · RiskMaterialised

Impairment resulting from an earnings shortfall in the quinoxyfen business

First written in FY2024. 1 of 1 entries say "Materialised", first in FY2024. Latest entry: FY2024.

1entries
1years
0from disclosures
Share on X
How it moved
Same theme, other companies
Impairment risk for real estate and fixed assets due to land prices, profitability, and deteriorating market conditionsA theme 403 companies write about · 418 as a headwind · 0 as a tailwind

Nissan Chemical moved to the "Worse" side of this theme in 2024, 3 years after the typical company in this theme (2021).

The whole theme swung hardest in 2020: 51 of 96 companies on the "Worse" side.

67 other companies' latest entry also says "Materialised".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 189 companies compared. The sentences above are computed from all 189.Comparing 200 of the theme's 418 threads.
Full recordFilings, disclosures and news, newest first
  1. FY2024MaterialisedAnnual report

    「Because the initially projected earnings from the Company’s quinoxyfen business could no longer be expected, its carrying amount was reduced to its recoverable amount, and the reduction was recorded as an impairment loss under extraordinary losses.」

    The initially projected revenue from the quinoxyfen business was no longer expected, and an impairment loss of ¥823 million was recognized.
Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next
No upcoming earnings preview for Nissan Chemical yet.
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Impairment resulting from an earnings shortfall in the quinoxyfen business | Nissan Chemical Corporation (4021) | Komori